February 3, 2015 Using its patented process, International Stem Cell has completed the manufacturing of its master cell bank of more than 2.6 billion clinical-grade human neural stem cells. The California biotech company says its existing master cell bank and current production scale are sufficient to meet foreseeable clinical trial requirements, including for the recently announced phase 1/2a clinical trial in Parkinson's disease.
http://ift.tt/1Day54D
http://ift.tt/1Day54D
No comments:
Post a Comment